Amylin's physiology and its role in diabetes

Current Opinion in Endocrinology and Diabetes

Volumn 4, Issue 4, 1997, Pages 282-290

  Young, Andrew A ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000184757     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199708000-00006     Document Type: Article

References (3)

1. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Bogardus C: Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab 1986, 62:922-927.
2. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990, 322:223-228.
3. Gerich JE, Lorenzi M, Hane S, Gustafson G, Guillemin R, Forsham PH: Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: studies with somatostatin. Metabolism 1975, 24:175-182.